INTRODUCTION

B
reast cancer is the most frequent malignant neoplasm in the female population, representing a public health problem on a global scale [1] [2] [3] Survival is the most used parameter to evaluate the results of the diagnosis and treatment of a malignant tumor with observations obtained in health records [9] [10] [11] . The age of the patient at diagnosis, tumor size, number of lymph nodes involved, degree of tumor differentiation, molecular subtype and clinical staging are the main parameters used to evaluate survival and play a fundamental role in the therapeutic planning of this neoplasia [10] [11] [12] .
Survival studies are important in the evaluation of the distribution of resources and in the identification of the main prognostic factors in a given region and population. However, few data are available on population-based breast cancer survival. This study aimed to evaluate the overall survival of women with breast cancer residing in Goiânia.
METHODS
This is a retrospective, population-based, overall survival study that included women living in the city
Goiânia Population-Based Cancer Registry (RCBPGO)
The RCBPGO, created in 1986, represents one of the most important cancer registries in Brazil and has worked continuously since its creation until the present day 13 . Incident cases are collected from general hospitals, cancer hospitals, specialized clinics and diagnostic centers. Periodically, the service coordinator evaluates these sources, taking into account the provision of complete data or the difficulty of attending 13 .
For case inclusion criteria, the registry classifies and 
Study population
We selected the sample through the RCBP- 
Data collection
We modified the questionnaire used to collect the variables based on a previous study carried out 
Data analysis
We divided overall survival into groups of five and ten years of follow-up. We counted time 
Ethical aspects
The present study was approved by the Ethics In the five-year multivariate analysis adjusted for tumor size, the cumulative risk of death from breast cancer was higher among women with histological grade G3, with lymph node involvement, negative PR, more advanced staging (T3 / T4) and metastatic disease ( Table 2 ). For the ten-year analysis, in addition to the factors found in the five-year one, the c-erb-B2 variable was also significant (Table 3) . 
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DISCUSSION
The epidemiological data on breast cancer in Goiânia 6,8,14 , as well as the variation in incidence in recent years 15 , have been described periodically.
However, few survival studies were performed using data from population-based registries. In this scenario, stands out the RCBPGO, whose data were the source of three previous survival studies that included women between 1988 and 1990 10 , 1990-1994 9 and 1995-2003 (present series). Despite the methodological differences, we observed an increase in survival from one series to the other, corresponding to 57%, 65.4% and 72.1%, respectively. This increase was possibly related to improvements in local screening and diagnosis of breast cancer [16] [17] [18] , which led to a reduction in advanced cases and an increase in initial cases 14, 19 . The inclusion of new targeted drugs and therapies should also have contributed to this outcome improvement 20, 21 .
Recently the CONCORD-2 study was published, which evaluated more than 25,000,000 people mes. The CONCORD-2 study evaluated net survival, in which the outcome for survival analysis is only death related to breast cancer, with deaths related to other causes considered as censorship 3 . We evaluated overall survival, for which all patient deaths were considered as outcome. Thus, the difference found relates to the methodological question and not to information divergence 22 .
Other studies conducted in Brazil, using data from hospital-based cancer registries, also found overall survival at five years similar to the present one, In Europe, the ONCOPOOL study evaluated 16,944 women treated at ten reference centers for breast cancer between 1990 and 1999. Overall survival at ten years was 80%. In this study, we highlight the difference in survival between the patients who received the diagnosis through screening programs (84%) and those diagnosed on physical examination (76%) 1 . The divergences found between the European study and this series are possibly due to the absence of a population screening program for breast cancer and inadequate mammography coverage in Brazil 18, 19 .
These data reinforce the current recommendations of the Brazilian Mastology Society, which warrants the screening of breast cancer from age 40 onwards 27 .
In the five-year multivariate analysis, adjusted for tumor size, factors influencing the prognosis were axillary lymph nodes, histological grade, progesterone receptor expression, T staging, and disease extent (Table 2 ). These data are in agreement with other hospital-based studies that evaluated women with breast cancer at reference centers for the diagnosis and treatment of breast cancer 12, 23, 24 .
The c-erb-B2 variable was only significant in the ten-year multivariate analysis (Table 3 ). The high number of "no information" for this variable ( Table found should reflect what happens to the majority of the Brazilian population. We should also note that the overall survival in ten years is below that observed in other countries 1, 26 and therefore, that resources related to early diagnosis and treatment should be better provided to the Brazilian population.
